| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 23.555 | 26.841 | 32.168 | 36.024 | 39.053 | 39.029 | 37.589 | 31.459 | 105.726 |
| Total Income - EUR | 0 | 23.556 | 26.842 | 32.168 | 36.028 | 39.327 | 39.393 | 37.635 | 31.460 | 105.865 |
| Total Expenses - EUR | 321 | 20.262 | 18.245 | 18.245 | 23.331 | 23.292 | 22.746 | 22.068 | 39.832 | 57.804 |
| Gross Profit/Loss - EUR | -321 | 3.294 | 8.596 | 13.923 | 12.697 | 16.035 | 16.647 | 15.567 | -8.372 | 48.061 |
| Net Profit/Loss - EUR | -321 | 3.058 | 8.328 | 13.602 | 12.337 | 15.647 | 16.253 | 15.042 | -8.686 | 45.358 |
| Employees | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 1 | 1 | 2 |
Check the financial reports for the company - Cliniqa Dumbravita S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 610 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 45 | 4.073 | 9.370 | 15.007 | 26.997 | 28.571 | 34.662 | 18.350 | 12.846 | 56.344 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.753 | 5.543 | 5.929 | 4.679 | 13.510 | 3.234 | 3.826 | 5.511 | 1.321 |
| Cash | 45 | 2.321 | 3.828 | 9.078 | 22.318 | 15.062 | 31.429 | 14.524 | 7.335 | 55.023 |
| Shareholders Funds | -276 | 2.785 | 8.372 | 13.644 | 25.717 | 27.792 | 32.186 | 15.083 | -242 | 44.583 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 0 | 0 | 0 |
| Debts | 931 | 1.289 | 999 | 1.363 | 1.280 | 779 | 2.477 | 3.267 | 13.087 | 11.761 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cliniqa Dumbravita S.r.l.